companydata.dkWeco Biotech ApS: Financial statements 2018
CVR: 36938587
Weco Biotech ApS (CVR 36938587) has filed annual accounts for 2018. In 2018, the company reported a net result of DKK 363,479,000 compared with DKK 111,560 the year before. Equity amounted to DKK 426,941,000. The solvency ratio was 100%.
- Profit/Loss
- 363,479,000 kr.
- Equity
- 426,941,000 kr.
- Total Assets
- 427,147,000 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | - | 363.5 mio. | 426.9 mio. | - |
| 2017 | - | - | 112 t. | 7 mio. | - |
| 2016 | - | - | 133 t. | 6.9 mio. | - |
Keep an eye on Weco Biotech ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2018
Weco Biotech ApS has published its annual report for 2017. The net result was DKK 111,560.
About Weco Biotech ApS
Weco Biotech ApS is a Danish company of the type Anpartsselskab based in Rungsted Kyst, founded in 2015. The company is registered under the industry Anden finansiel formidling i.a.n.. The management consists of Johan Ernst Wedell-Wedellsborg. The company is owned by WECO A/S. In 2025, the company reported a gross profit of DKK -83,000 and a net result of DKK -542,000 compared with DKK 35,061,000 the year before. Equity amounted to DKK 229,113,000.